Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3284342 | Clinical Gastroenterology and Hepatology | 2009 | 8 Pages |
Abstract
Community gastroenterologists and UC experts vary dramatically in their approach to many areas of uncertainty in UC. The only area of consensus between groups is the use of infliximab over cyclosporine in steroid-refractory UC, itself a controversial decision. These data suggest that current practice patterns are highly disparate and focus attention on specific areas of disconnect that should be further investigated.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Brennan M.R. Spiegel, Wayne Ho, Eric Esrailian, Stephan Targan, Peter D.R. Higgins, Corey A. Siegel, Marla Dubinsky, Gil Y. Melmed,